9926.HK 財務： Akeso, Inc. AI 分析

Q: 技術分析指標如何適用於 9926.HK？

根據技術分析，Akeso, Inc. 的綜合信號為 Buy。Akeso, Inc. 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 9926.HK 的費波那契回檔水準是多少？

Akeso, Inc. 的費波那契回檔水準是 低於 100% 水準。

Q: Akeso, Inc. 的 RSI 是多少？

Akeso, Inc. 的 RSI 目前為 49.07，表明處於 中立 狀態

Q: Akeso, Inc. 接下來 12 個月的價格是多少？

Akeso, Inc. 9926.HK 接下來 12 個月的價格預估為 $173.04。

Q: Akeso, Inc. 預計會漲到多高？

據華爾街分析師稱，Akeso, Inc. 預計將達到 $237.3 的高預測值。

首頁

股票

9926.HK

預測

AKESO (9926.HK)

Akeso, Inc.

HK$117.1

-3.22%

$-3.9

盤中： Jan 19, 15:04:15 HKT

關鍵數據

前收市價

$121

開盤價

$121

當日範圍

$117 - $121

52週區間

$55.65 - $179

交易量

3.7M

平均成交量

6.6M

每股盈餘 (TTM)

-1.07

股息收益率

市值

$107.8B

什麼是 AKESO？

Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 9926.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $173.04. The lowest target is $101 and the highest is $237.3. Empower your investment choices with our cutting-edge, data-driven analysis!

9926.HK 股價預測摘要

9926.HK 的頂級分析師評級

根據 29 位分析師對 9926.HK 的股票評級，更新於 Jan 01, 2026

Strong Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for 9926.HK. Our analysts highlight strong fundamentals and favorable market sentiment, positioning 9926.HK for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: 9926.HK is a Strong Buy candidate.

9926.HK stock price ended at $121 on 星期五, after dropping 0.74%

On the latest trading day Jan 16, 2026, the stock price of 9926.HK fell by 0.74%, dropping from $122.30 to $121.00. During the session, the stock saw a volatility of 3.29%, with prices oscillating between a daily low of $118.60 and a high of $122.50. On the latest trading day, the trading volume for 9926.HK rose by 1.9M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 5.1M shares were traded, with a market value of approximately $111.4B.

9926.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

9926.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於下跌趨勢狀態，在此期間價格總共變動了 -1.94%。整體而言，技術指標顯示中期後市趨勢為 Buy。

9926.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為9926.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 9926.HK？



9926.HK 的費波那契回檔水準是多少？



Akeso, Inc. 的 RSI 是多少？



Akeso, Inc. 接下來 12 個月的價格是多少？



Akeso, Inc. 預計會漲到多高？



Akeso, Inc.（9926.HK）價格

9926.HK 股價走勢圖